Clinical Trials

NCT04668300 | ACTIVE_NOT_RECRUITING | PHASE2
75 participants

Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2020-11-26
Completion:
2027-06-30
Conditions
  • Metastatic Angiosarcoma
  • Metastatic Dedifferentiated Liposarcoma
  • Metastatic Osteosarcoma
  • Recurrent Angiosarcoma
  • Recurrent Dedifferentiated Liposarcoma
  • Recurrent Osteosarcoma
  • Refractory Dedifferentiated Liposarcoma
  • Refractory Osteosarcoma
Interventions
  • BIOLOGICAL
No Results Yet
NCT04556916 | RECRUITING | NA
320 participants

Early Detection of Prostate Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2021-02-19
Completion:
2023-11-15
Conditions
  • Prostate Cancer
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT04545762 | RECRUITING | PHASE1
36 participants

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-22
Start Date:
2020-09-11
Completion:
2026-10-31
Conditions
  • Refractory Non-Hodgkin Lymphoma
  • Burkitt Lymphoma
  • Mantle Cell Lymphoma
  • Follicular Lymphoma
  • Lymphoplasmacytic Lymphoma
  • Primary Mediastinal Large B Cell Lymphoma
  • Diffuse Large B Cell Lymphoma
  • Small Lymphocytic Lymphoma
  • Transformed Lymphoma
  • Non-Hodgkin Lymphoma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page